ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
126.922,11
-0,99%
S&P 500
5.948,71
0,53%
US Dollar vs BRL
5,817
0,02%
Bitcoin
98.353,56
-0,16%
Brent Oil
73,93
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Axogen Inc (AXGN)

  7. Axogen Inc (AXGN) Notícias

AXGN

Axogen (AXGN)

Axogen Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:AXGN
DataHoraFonteTítuloCódigoCompanhia
14/11/202417:31Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AXGNAxogen Inc
07/11/202418:34Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:AXGNAxogen Inc
07/11/202418:12Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AXGNAxogen Inc
07/11/202412:52Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
07/11/202409:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
07/11/202409:00GlobeNewswire Inc.Axogen, Inc Reports Third Quarter 2024 Financial Results and Provides BLA UpdateNASDAQ:AXGNAxogen Inc
24/10/202408:00GlobeNewswire Inc.Axogen, Inc. to report third quarter 2024 financial results and host conference call on November 7, 2024NASDAQ:AXGNAxogen Inc
17/09/202417:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
06/09/202408:00GlobeNewswire Inc.Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®NASDAQ:AXGNAxogen Inc
03/09/202408:00GlobeNewswire Inc.Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)NASDAQ:AXGNAxogen Inc
13/08/202417:18GlobeNewswire Inc.CytoSorbents Appoints Peter J. Mariani Chief Financial OfficerNASDAQ:AXGNAxogen Inc
09/08/202417:36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AXGNAxogen Inc
09/08/202417:15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
08/08/202408:05GlobeNewswire Inc.Axogen, Inc. Announces New Leadership AppointmentsNASDAQ:AXGNAxogen Inc
08/08/202408:00GlobeNewswire Inc.Axogen, Inc. Reports Second Quarter 2024 Financial ResultsNASDAQ:AXGNAxogen Inc
23/07/202408:00GlobeNewswire Inc.Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024NASDAQ:AXGNAxogen Inc
01/07/202408:00GlobeNewswire Inc.Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:AXGNAxogen Inc
24/06/202408:00GlobeNewswire Inc.Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™NASDAQ:AXGNAxogen Inc
28/05/202417:30GlobeNewswire Inc.Axogen Processing Center (APC) Celebrates its Opening with Ohio Leaders in VandaliaNASDAQ:AXGNAxogen Inc
16/05/202408:00GlobeNewswire Inc.Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®NASDAQ:AXGNAxogen Inc
14/05/202408:00GlobeNewswire Inc.Axogen, Inc to Participate at Leerink Partners Healthcare Crossroads ConferenceNASDAQ:AXGNAxogen Inc
02/05/202408:00GlobeNewswire Inc.Axogen, Inc Reports First Quarter 2024 Financial ResultsNASDAQ:AXGNAxogen Inc
29/04/202417:50GlobeNewswire Inc.Axogen Announces First Surgical Implants of Avive+ Soft Tissue Matrix™NASDAQ:AXGNAxogen Inc
16/04/202408:00GlobeNewswire Inc.Axogen, Inc. to Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024NASDAQ:AXGNAxogen Inc
06/03/202410:53Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:AXGNAxogen Inc
06/03/202410:45Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:AXGNAxogen Inc
05/03/202409:00GlobeNewswire Inc.Axogen, Inc Reports 2023 Fourth Quarter and Full-Year Financial ResultsNASDAQ:AXGNAxogen Inc
14/02/202417:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AXGNAxogen Inc
13/02/202418:30GlobeNewswire Inc.Axogen, Inc. to Report 2023 Fourth Quarter and Full-Year Financial Results on March 5, 2024NASDAQ:AXGNAxogen Inc
12/02/202415:21Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AXGNAxogen Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:AXGN

Seu Histórico Recente

BOV
BOBR4
BOMBRIL PN
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados